about
Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancerObesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesAdrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptorsAnatomy of the adipose organ.Are there functional β₃-adrenoceptors in the human heart?Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature.Inhibitory effects of SR 58611A on canine colonic motility: evidence for a role of beta 3-adrenoceptorsPotentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Characterization of beta-adrenoceptor mediated smooth muscle relaxation and the detection of mRNA for beta1-, beta2- and beta3-adrenoceptors in rat ileum.Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and beta(3)-adrenoceptor knockout mice.The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesityFunctional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscleAn association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances.A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.β(3)-Adrenoceptor Antagonist SR59230A Attenuates the Imbalance of Systemic and Myocardial Oxygen Transport Induced by Dopamine in Newborn LambsComparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.Expression of beta 3-adrenoceptor mRNA in rat tissues.(-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptorRespective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues.Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.Beta3-adrenoceptor agonist stimulation of the Na+, K+ -pump in rat skeletal muscle is mediated by beta2- rather than beta3-adrenoceptors.Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteersHypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue.Challenges in β(3)-Adrenoceptor Agonist Drug DevelopmentCharacterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.Are defects in energy expenditure involved in the causation of obesity?Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist.The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts.The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.β(3)-Adrenoceptor ligand development history through patent review.Long term phorbol ester treatment down-regulates the beta 3-adrenergic receptor in 3T3-F442A adipocytes.Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice.β3 -AR and the vertebrate heart: a comparative view.Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanismsPotentiation of potassium currents by beta-adrenoceptor agonists in human urinary bladder smooth muscle cells: a possible electrical mechanism of relaxation.Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta 4-adrenoceptor' in mammalian heart.
P2860
Q24800485-81EAFA91-FA6B-400D-A374-D923389FFFA3Q28088325-9B54B822-5CB0-487D-A76E-1AFC2F3AFCFBQ28379477-856EBAFB-A853-44B8-85DD-860178E6EF0BQ34084874-CD844FC3-471B-4A3D-B8FF-180FC50FF352Q34588651-5025BDC5-07CF-4430-8F22-B2B36034C68CQ34588659-D9261630-E052-40C4-A082-4E97EFAF822EQ34793093-EB5A2869-C6DB-4D3E-A559-CF29786D8018Q34793626-96F5CEBB-B9A9-409C-809B-2B294B93EE3AQ34837191-C960F71D-0A58-4EC7-9E20-481F7E5964B6Q35029000-B933A523-3F2C-48F9-99F2-F81F20A0A0A5Q35042344-1AA13305-A914-4DEA-8D25-F33CBD521C3FQ35044965-CF2FE6B1-8F99-42C6-837A-7A8A7995ECB6Q35175151-26E04B6B-D124-4097-9E88-44143A681C9CQ35361261-3EC4D353-6E4F-464A-B44A-ACA257C4B6E8Q35547285-BE605998-7BB8-44C4-BEA1-FBFCB842C70BQ35553029-E1C3F59F-55F9-46A0-B694-3819A9ADCC19Q35828649-9733A787-2C21-4956-B92C-B1036266B955Q35873282-A201D00B-1D3E-4C1F-A2E5-C9CB1E8A9810Q35873351-9DDEDBDA-93B7-435D-8ACC-03C8558D8BADQ35873372-59CBE1C3-7E4B-463B-BB62-7A97F17EB910Q35873569-4BA26BA2-0C3B-4073-936D-64859CB6D5FAQ35874092-AFBD5AB9-CD14-46D3-9778-7D504E4F5729Q36054398-EC0EBD17-AC89-4D05-91B2-056766A22F98Q36055061-5DAD8941-CA2D-4412-BA19-E7B7F5B42928Q36106687-E308DF39-CB4A-4FB2-850E-42571B8D2592Q36327996-89D8DA8C-E3AB-4BF7-813B-DB00DB36FA77Q36329658-14C42716-C819-4398-9A5E-0CC4FB9A7D87Q36742617-69C0CC34-A5BA-404D-AF06-E44D2EC18868Q36916953-BF7075D3-4077-4804-B0C4-A33A7A3343E7Q37129351-949889FC-51B8-4426-B7AE-FFB8BF0F181CQ37356667-4A31E458-F3F5-4047-8CF1-9B43618C0B01Q37361164-39F05EED-9745-4AB5-9F43-A969BDACE542Q37385274-C46C09A1-950B-41FA-BB5E-AB5EA0A6852AQ37853580-6A3C3E1E-6ACB-4D11-B256-FFC2A27C7789Q38295535-DBE3B9FD-F4EC-4A58-B2F3-FA5582099FDFQ38297022-A9214A3B-1D95-44AF-A76F-D57C86384D64Q38391176-1382E983-A038-44E6-B682-FD40F2DDA249Q39972489-4173D02E-E453-4C3F-BE49-E5D981D598FBQ40016139-64158093-1D16-429D-8F82-EEF9E00A4993Q40881487-757E909F-0D1E-4AB3-A5E7-1B487FA2DFFF
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Beta 3 and atypical beta-adrenoceptors.
@en
type
label
Beta 3 and atypical beta-adrenoceptors.
@en
prefLabel
Beta 3 and atypical beta-adrenoceptors.
@en
P356
P1476
Beta 3 and atypical beta-adrenoceptors.
@en
P2093
P304
P356
10.1002/MED.2610130604
P577
1993-11-01T00:00:00Z